메뉴 건너뛰기




Volumn 48, Issue 6 SUPPL., 1996, Pages 62-66

Usefulness of the ratio free/total prostate-specific antigen in addition to total PSA levels in prostate cancer screening

Author keywords

[No Author keywords available]

Indexed keywords

PROSTATE SPECIFIC ANTIGEN;

EID: 17144466104     PISSN: 00904295     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0090-4295(96)00612-7     Document Type: Article
Times cited : (48)

References (20)
  • 4
    • 0027226031 scopus 로고
    • Detection of organ-confined prostate cancer is increased through prostate-specific antigen-based screening
    • Catalona WJ, Smith DS, Ratliff TL, and Basler IW: Detection of organ-confined prostate cancer is increased through prostate-specific antigen-based screening. JAMA 270: 948-954, 1993.
    • (1993) JAMA , vol.270 , pp. 948-954
    • Catalona, W.J.1    Smith, D.S.2    Ratliff, T.L.3    Basler, I.W.4
  • 5
    • 0028787810 scopus 로고
    • Comparison of different prostate specific antigen cutpoints for early detection of prostate cancer: Results of a large screening study
    • Reissigl A, Pointner J, Horninger W, Ennemoser O, Strasser H, Klocker H, and Bartsch G.: Comparison of different prostate specific antigen cutpoints for early detection of prostate cancer: results of a large screening study. Urology 46: 662-665, 1995.
    • (1995) Urology , vol.46 , pp. 662-665
    • Reissigl, A.1    Pointner, J.2    Horninger, W.3    Ennemoser, O.4    Strasser, H.5    Klocker, H.6    Bartsch, G.7
  • 7
    • 0026027671 scopus 로고
    • 1 antichymotrypsin is the major form of prostate-specific antigen in serum of patients with prostate cancer: Assay of the complex improves clinical sensitivity for cancer
    • 1 antichymotrypsin is the major form of prostate-specific antigen in serum of patients with prostate cancer: assay of the complex improves clinical sensitivity for cancer. Cancer Res 51: 222-226, 1991.
    • (1991) Cancer Res , vol.51 , pp. 222-226
    • Stenman, W.H.1    Leinonen, I.2    Alfthon, H.3    Ramikko, S.4    Tukkanen, K.5    Alfthan, O.6
  • 10
    • 0028800933 scopus 로고
    • Evaluation of percentage of free serum prostate-specific antigen to improve specificity of prostate cancer screening
    • Catalona WJ, Smith DS, Wolfert RL, Wang TJ, Rittenhouse HG, Ratliff TL, and Nadler RB: Evaluation of percentage of free serum prostate-specific antigen to improve specificity of prostate cancer screening. JAMA 274: 1214-1220, 1995.
    • (1995) JAMA , vol.274 , pp. 1214-1220
    • Catalona, W.J.1    Smith, D.S.2    Wolfert, R.L.3    Wang, T.J.4    Rittenhouse, H.G.5    Ratliff, T.L.6    Nadler, R.B.7
  • 12
    • 0029933686 scopus 로고    scopus 로고
    • Using proportions of free to total prostate-specific antigen, age, and total prostate-specific antigen to predict the probability of prostate cancer
    • Chen Y-T, Luderer AA, Thiel RP, Carlson G, Cuny CL, and Soriano TF: Using proportions of free to total prostate-specific antigen, age, and total prostate-specific antigen to predict the probability of prostate cancer. Urology 47: 518-524, 1996.
    • (1996) Urology , vol.47 , pp. 518-524
    • Chen, Y.-T.1    Luderer, A.A.2    Thiel, R.P.3    Carlson, G.4    Cuny, C.L.5    Soriano, T.F.6
  • 13
    • 0029997813 scopus 로고    scopus 로고
    • Clinical significance of the determination of noncomplexed prostate-specific antigen as a marker for prostate carcinoma
    • Froschermaier SE, Pilarsky CP, and Wirth MP: Clinical significance of the determination of noncomplexed prostate-specific antigen as a marker for prostate carcinoma. Urology 47: 525-528, 1996.
    • (1996) Urology , vol.47 , pp. 525-528
    • Froschermaier, S.E.1    Pilarsky, C.P.2    Wirth, M.P.3
  • 14
    • 0343811453 scopus 로고    scopus 로고
    • Improvement of prostate cancer screening by determination of the ratio free/total prostate-specific antigen in addition to prostate specific antigen levels
    • in press
    • Reissigl A, Klocker H, Pointner J, Ennemoser O, Falk M, and Bartsch G: Improvement of prostate cancer screening by determination of the ratio free/total prostate-specific antigen in addition to prostate specific antigen levels. Prostate, in press.
    • Prostate
    • Reissigl, A.1    Klocker, H.2    Pointner, J.3    Ennemoser, O.4    Falk, M.5    Bartsch, G.6
  • 15
    • 0027244140 scopus 로고
    • Serum prostate-specific antigen in a community-based population of healthy men. Establishment of age-specific reference ranges
    • Oesterling JE, Jacobsen SJ, Chute CG, Guess HA, Girman CJ, Panser LA, and Lieber MM: Serum prostate-specific antigen in a community-based population of healthy men. Establishment of age-specific reference ranges. JAMA 270: 860-864, 1993.
    • (1993) JAMA , vol.270 , pp. 860-864
    • Oesterling, J.E.1    Jacobsen, S.J.2    Chute, C.G.3    Guess, H.A.4    Girman, C.J.5    Panser, L.A.6    Lieber, M.M.7
  • 17
    • 0028939781 scopus 로고
    • A comparison of prostate-specific antigen, prostate specific membrane antigen, and LNCaP based enzyme-linked immonosorbent assays in prostatic cancer patients and patients with benign prostatic enlargement
    • Murphy GP, Holmes EH, Boynton AL, Kenny GM, Ostenson RC, Erickson SJ, and Barren RJ: A comparison of prostate-specific antigen, prostate specific membrane antigen, and LNCaP based enzyme-linked immonosorbent assays in prostatic cancer patients and patients with benign prostatic enlargement. Prostate 26: 164-168, 1995.
    • (1995) Prostate , vol.26 , pp. 164-168
    • Murphy, G.P.1    Holmes, E.H.2    Boynton, A.L.3    Kenny, G.M.4    Ostenson, R.C.5    Erickson, S.J.6    Barren, R.J.7
  • 18
    • 0025869392 scopus 로고
    • Prostate specific antigen: A critical assessment of the most useful tumor marker for adenocarcinoma of the prostate
    • Oesterling JE: Prostate specific antigen: a critical assessment of the most useful tumor marker for adenocarcinoma of the prostate. J Urol 145: 907-923, 1991.
    • (1991) J Urol , vol.145 , pp. 907-923
    • Oesterling, J.E.1


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.